SUPERNUS PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Supernus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $15.3M, a 1205% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $73.9M, a 5513% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $73.9M, a 5513% increase from 2023.
  • Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $1.32M, a 97.8% decline from 2022.
  • Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $60.7M, a 13.6% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $73.9M +$72.5M +5513% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $1.32M -$59.4M -97.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $60.7M +$7.29M +13.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $53.4M -$73.5M -57.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $127M +$13.9M +12.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $113M +$2.06M +1.86% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $111M +$53.7M +93.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $57.3M -$33.9M -37.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $91.2M +$77.3M +554% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $13.9M +$24.9M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$10.9M +$81.3M +88.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$92.3M -$46M -99.4% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 -$46.3M -$100M -186% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $53.8M +$92.3M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 -$38.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.